Human Immunodeficiency Virus (HIV)–Specific IgA and HIV Neutralizing Activity in the Serum of Exposed Seronegative Partners of HIV‐Seropositive Persons
Sandra Mazzoli(Ospedale Santa Maria Annunziata), Mario Clerici(University of Milan), Francesca Semplici(Imperial College London), Antonio G. Siccardi(San Raffaele University of Rome), Mara Biasin(University of Milan), Claudia Pastori(Vita-Salute San Raffaele University), Daria Trabattoni(University of Milan), Sergio Lo Caputo(Ospedale Santa Maria Annunziata), Francesco Mazzotta(Ospedale SS. Annunziata), Claudio Blé(Ospedale SS. Annunziata), Alessandra Salvi(Ospedale SS. Annunziata), Francesca Meacci(Ospedale SS. Annunziata), Lucia Lopalco(Vita-Salute San Raffaele University), Maria Luisa Villa(University of Milan), Antonio Cosma(Luxembourg Institute of Health)
Cited by 138
Related Papers
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
|Nature Medicine|1997|635
Guidelines for the use of flow cytometry and cell sorting in immunological studies <sup>*</sup>
|European Journal of Immunology|2017|554
Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2001|470
Control of HIV despite the Discontinuation of Antiretroviral Therapy
|New England Journal of Medicine|1999|328